bpc-157 myelin Buy (15mg) | Order Research Peptides BPC-157 Delayed 60c by InfiniWell

The "gradual decline" group (approximately 40-50% of users) represents modal experience where benefits slowly regress toward pre-treatment baseline over 4-8 months, typically affecting users who completed shorter treatment courses (2-4 months), used lower concentrations or inconsistent application, possessed moderate to severe baseline skin damage requiring ongoing support, maintained adequate but not optimal complementary skincare, experienced significant lifestyle stressors affecting skin health including poor sleep or high stress, and faced genetic or age-related collagen production limitations

You might attribute this to a plateau, to your body adapting, to needing a higher dose

It does not make BPC-157 generally legal

Corticosteroid injection is an accepted treatment option for medial and lateral epicondylitis